Recent News

• 02.04.2026 - Avalo Therapeutics to Participate in Upcoming Investor Conferences
• 11.17.2025 - Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 01.30.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.29.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.20.2026 - EFFECT Notice of Effectiveness
• 01.12.2026 - 8-K Current report
• 01.12.2026 - EX-99.1 EX-99.1
• 01.08.2026 - S-3 Registration statement under Securities Act of 1933
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 12.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.12.2025 - 4 Statement of changes in beneficial ownership of securities